VCIM
QNRX

Velan Capital Investment Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Velan Capital Investment Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Sell
32,372
-52,477
-62% -$283K 0.1% 44
2026
Q1 		$560K Buy
+84,849
New +$769K 0.35% 27

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Velan Capital Investment Management's QNRX Position: Q2 2026 in Review

Velan Capital Investment Management reduced its Quoin Pharmaceuticals (QNRX) stake by 62% in Q2 2026, selling an estimated $283K and leaving 32,372 shares worth $157K. The position accounts for 0.1% of the portfolio, ranked #44.

Velan Capital Investment Management first reported a position in QNRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $560K in Q1 2026. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Velan Capital Investment Management held 32,372 shares of Quoin Pharmaceuticals worth $157K as of Q2 2026.
  • Velan Capital Investment Management sold 52,477 Quoin Pharmaceuticals shares in Q2 2026, an estimated $283K.
  • Quoin Pharmaceuticals made up 0.1% of Velan Capital Investment Management's portfolio in Q2 2026, its #44 holding.
  • Velan Capital Investment Management first reported a position in Quoin Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Velan Capital Investment Management's Quoin Pharmaceuticals position peaked at $560K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.